Cerenome Names Director Ron Andrews Chief Business Officer
- Cerenome appointed Ron Andrews as chief business officer, a newly created position.
- Andrews will lead business development and commercial strategy, focusing on expanding CNSide diagnostics adoption and developing strategic partnerships.
- He previously served as CEO of Clarient and Oncocyte, bringing more than 35 years of diagnostics industry leadership experience.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cerenome Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611100730PRIMZONEFULLFEED9874072) on November 10, 2026, and is solely responsible for the information contained therein.